CONTRIBUTORS

Harold Varmus is president of the Memorial Sloan-Kettering Cancer Center since 2000, and took the position after serving for more than six years as director of the NIH. The 1989 Nobel Prize winner is also a cofounder of the Public Library of Science and a member of the Science Initiative Group (SIG). On page 24, he makes the case for Global Science Corps, a SIG program that aims to place well-trained scientists and engineers in the research centers of developing countries to collab

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Harold Varmus is president of the Memorial Sloan-Kettering Cancer Center since 2000, and took the position after serving for more than six years as director of the NIH. The 1989 Nobel Prize winner is also a cofounder of the Public Library of Science and a member of the Science Initiative Group (SIG). On page 24, he makes the case for Global Science Corps, a SIG program that aims to place well-trained scientists and engineers in the research centers of developing countries to collaborate with their hosts on topics of local concern.

H. Steven Wiley, director of Pacific Northwest National Laboratory's Biomolecular Systems Initiative, has been performing quantitative studies of the epidermal growth factor receptor since he first modeled its binding and internalization in 1982. On page 52, he writes on the future of systems biology. "In the last 25 years, we've learned an enormous amount based on genomics, proteomics... and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies